These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24260365)

  • 1. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism.
    Ali N; Allam H; Bader T; May R; Basalingappa KM; Berry WL; Chandrakesan P; Qu D; Weygant N; Bronze MS; Umar S; Janknecht R; Sureban SM; Huycke M; Houchen CW
    PLoS One; 2013; 8(11):e80304. PubMed ID: 24260365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the molecular mechanism of host-based statin resistance in hepatitis C virus replicon containing cells.
    Delang L; Scheers E; Grabner M; Verpaalen B; Helsen N; Vanstreels E; Daelemans D; Verfaillie C; Neyts J
    Biochem Pharmacol; 2015 Aug; 96(3):190-201. PubMed ID: 26070251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatin.
    Wuestenberg A; Kah J; Singethan K; Sirma H; Keller AD; Rosal SR; Schrader J; Loscher C; Volz T; Bartenschlager R; Lohmann V; Protzer U; Dandri M; Lohse AW; Tiegs G; Sass G
    PLoS One; 2014; 9(5):e96533. PubMed ID: 24801208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.
    Ali N; Chandrakesan P; Nguyen CB; Husain S; Gillaspy AF; Huycke M; Berry WL; May R; Qu D; Weygant N; Sureban SM; Bronze MS; Dhanasekaran DN; Houchen CW
    Oncotarget; 2015 Aug; 6(24):20327-44. PubMed ID: 25948779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.
    Ali N; Allam H; May R; Sureban SM; Bronze MS; Bader T; Umar S; Anant S; Houchen CW
    J Virol; 2011 Dec; 85(23):12292-303. PubMed ID: 21937640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
    Ikeda M; Abe K; Yamada M; Dansako H; Naka K; Kato N
    Hepatology; 2006 Jul; 44(1):117-25. PubMed ID: 16799963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients.
    Milazzo L; Meroni L; Galazzi M; Cesari M; Caramma I; Marchetti G; Galli M; Antinori S
    J Viral Hepat; 2009 Jul; 16(7):479-84. PubMed ID: 19215577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.
    Ikeda M; Kawai Y; Mori K; Yano M; Abe K; Nishimura G; Dansako H; Ariumi Y; Wakita T; Yamamoto K; Kato N
    Liver Int; 2011 Jul; 31(6):871-80. PubMed ID: 21645219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression.
    Nguyen CB; Kotturi H; Waris G; Mohammed A; Chandrakesan P; May R; Sureban S; Weygant N; Qu D; Rao CV; Dhanasekaran DN; Bronze MS; Houchen CW; Ali N
    Cancer Res; 2016 Aug; 76(16):4887-96. PubMed ID: 27287718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism.
    Ali N; Nguyen CB; Chandrakesan P; Wolf RF; Qu D; May R; Goretsky T; Fazili J; Barrett TA; Li M; Huycke MM; Bronze MS; Houchen CW
    Sci Rep; 2020 Jun; 10(1):10578. PubMed ID: 32601309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deguelin inhibits HCV replication through suppressing cellular autophagy via down regulation of Beclin1 expression in human hepatoma cells.
    Liao W; Liu X; Yang Q; Liu H; Liang B; Jiang J; Huang J; Ning C; Zang N; Zhou B; Liao Y; Chen J; Tian L; Ho W; Abdullah AS; Kong L; Liang H; Chen H; Ye L
    Antiviral Res; 2020 Feb; 174():104704. PubMed ID: 31917237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α.
    Zhang X; Daucher M; Armistead D; Russell R; Kottilil S
    PLoS One; 2013; 8(2):e55733. PubMed ID: 23418453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase.
    Yang D; Xue B; Wang X; Yu X; Liu N; Gao Y; Liu C; Zhu H
    PLoS One; 2013; 8(5):e64932. PubMed ID: 23741428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of fluvastatin on influenza virus infection.
    Peng J; Zhang D; Ma Y; Wang G; Guo Z; Lu J
    Mol Med Rep; 2014 Jun; 9(6):2221-6. PubMed ID: 24676773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV replication and statin pleotropism: an adjuvant treatment panacea?
    Torres DM; Harrison SA
    Am J Gastroenterol; 2008 Jun; 103(6):1390-2. PubMed ID: 18479495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication.
    Ando M; Korenaga M; Hino K; Ikeda M; Kato N; Nishina S; Hidaka I; Sakaida I
    Liver Int; 2008 Sep; 28(8):1158-66. PubMed ID: 18410284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoregulatory control of microtubule binding in doublecortin-like kinase 1.
    Agulto RL; Rogers MM; Tan TC; Ramkumar A; Downing AM; Bodin H; Castro J; Nowakowski DW; Ori-McKenney KM
    Elife; 2021 Jul; 10():. PubMed ID: 34310279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin attenuated the effect of expression of β1 integrin in PAN-treated podocytes by inhibiting reactive oxygen species.
    Liu J; Zhang B; Chai Y; Xu Y; Xing C; Wang X
    Mol Cell Biochem; 2015 Jan; 398(1-2):207-15. PubMed ID: 25240415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life style-related diseases of the digestive system: cell culture system for the screening of anti-hepatitis C virus (HCV) reagents: suppression of HCV replication by statins and synergistic action with interferon.
    Ikeda M; Kato N
    J Pharmacol Sci; 2007 Oct; 105(2):145-50. PubMed ID: 17928739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.